Civetta Therapeutics
William R. Sellers is a Core Institute Member, Broad Institute, Professor of Medicine at HMS and DFCI. Former VP/Global Head of Oncology at Novartis Institute for Biomedical Research. Led preclinical drug discovery for 11 years, ~40 therapeutics entered phase I with 6 NDA approvals and multiple ongoing phase III programs. Co-led CART JSC with Carl June MD. Board member of Peloton Therapeutics, SAB member of Ideaya Biosciences and Epidarex Capital. Previously he co-led cancer genetic programs with Matthew Meyerson leading to the discovery of EGFR mutations in lung cancer, and the role of MITF in melanoma.
This person is not in the org chart
This person is not in any offices
Civetta Therapeutics
Civetta Therapeutics;s mission is to advance new medicines through small molecule intervention targeting propeller domains with the goal of developing important therapeutics for cancer and other indications.